Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

REFILE-US STOCKS-Dow advances, S&P ekes out gain as vaccine timeline comes into focus

Published 10/17/2020, 04:19 AM
Updated 10/17/2020, 04:30 AM

(Removes extra word in paragraph 1)
* U.S. retail sales accelerate in September
* Dow Jones Transport index drops
* Schlumberger posts third straight loss
* Indexes: Dow up 0.30%, S&P up 0.01%, Nasdaq down 0.36%

By Stephen Culp
NEW YORK, Oct 16 (Reuters) - The S&P 500 posted a nominal
gain on Friday as further clarity regarding the timeline for the
development of a coronavirus vaccine and much
better-than-expected retail sales data brought buyers back to
the market.
The Dow also joined the S&P in positive territory, both
indexes snapping a three-day losing streak driven by halted
vaccine trials and continued wrangling in Washington over a new
pandemic relief package. But the Nasdaq ended the session lower.

Even so, they all posted gains on the week.
Pfizer Inc PFE.N announced it could apply for U.S.
authorization for the COVID-19 vaccine it is developing with
German partner BioNTech 22UAy.F in November. Pfizer's stock
gained 3.8%. "The two highest-level market movers are the vaccine
timeline and stimulus optimism," said Ross Mayfield, investment
strategist at Baird in Louisville, Kentucky. "Sometimes the
market gets a reality check that even if we get a vaccine early
next year that's an incredibly aggressive and optimistic
timeline."
Retail sales USRSL=ECI in September blew past analyst
expectations and consumer sentiment for the current month
surprised to the upside, according to two separate economic
reports. But with previous stimulus having run its course, the
outlook is uncertain unless Washington can reach an agreement on
a fresh round of fiscal aid. "It's important from the retail sales data to see that the
consumer is not just limping a long but exceeding expectations,"
Mayfield added. "I don't know how long this can continue without
stimulus but it's heartening to see the consumer has held up
pretty well despite some dire expectations."
On the stimulus front, U.S. Treasury Secretary Steven
Mnuchin told House Speaker Nancy Pelosi that President Donald
Trump would "weigh in" with Senate Majority Leader Mitch
McConnell if an agreement is reached on a new pandemic relief
package. House Republican leader Kevin McCarthy, however, said
he does not expect an agreement to be reached ahead of the Nov.
3 election as long as Pelosi is involved. The Dow Jones Industrial Average .DJI rose 112.11 points,
or 0.39%, to 28,606.31, the S&P 500 .SPX gained 0.47 points,
or 0.01%, to 3,483.81 and the Nasdaq Composite .IXIC dropped
42.32 points, or 0.36%, to 11,671.56.
Of the 11 major sectors in the S&P 500, seven ended the
session in the black. While utilities .SPLRCU had the largest
percentage gain, energy .SPNY suffered the biggest loss.
Third-quarter reporting season burst from the starting gate
this week, with 49 of the companies in the S&P 500 having
reported. Of those, 86% have cleared the low bar set by
expectations, according to Refinitiv.
Oil services company Schlumberger NV SLB.N posted its
third straight quarterly loss due to falling crude prices and
plunging demand. Its shares dropped 8.8%. Railroad operator Kansas City Southern KSU.N shed 2.7% and
transportation and logistics company J.B. Hunt Transport
Services Inc JBHT.O tumbled 9.7% after the companies'
quarterly results were hit dropping shipping demand.
The Dow Jones Transport index .DJT , considered a barometer
of economic health, fell 1.3%. Shares of fitness company Peloton Interactive Inc PTON.O
lost 3.7% after announcing a recall of faulty pedals on its
popular exercise bikes.
Declining issues outnumbered advancing ones on the NYSE by a
1.30-to-1 ratio; on Nasdaq, a 1.07-to-1 ratio favored decliners.
The S&P 500 posted 50 new 52-week highs and no new lows; the
Nasdaq Composite recorded 98 new highs and 20 new lows.
Volume on U.S. exchanges was 8.82 billion shares, compared
with the 9.31 billion average over the last 20 trading days.



Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.